Why the study?
Effective targeted therapies for diabetic cardiomyopathy-related cardiac fibrosis and adverse remodeling remain lacking. Although p-coumaric acid has shown antihyperglycemic and antifibrotic potential, its mechanism of action and effects on cardiac cell crosstalk remained unexplored.
Population
Human cardiac fibroblasts, human umbilical vein endothelial cells, and AC16 cardiomyocytes
Comparison
p-coumaric acid treatment vs without p-coumaric acid treatment under glycemic and fibrotic conditions, with compound C exposure
Design
In vitro cell culture and conditioned media experiment
Answers are grounded in this paper and cite their sources.
Should not yet change diabetic cardiomyopathy management; hypothesis-generating for antifibrotic paracrine effects in cardiac fibroblasts.
Diabetic cardiomyopathy (DCM) is characterized by cardiac fibrosis and adverse remodeling, for which effective targeted therapies remain lacking. Previously, p-coumaric acid (PCA), a phenolic compound found in Phoenix dactylifera and Beta vulgaris, was demonstrated by us as having antihyperglycemic and antifibrotic potential, but its mechanism of action and effects on cardiac cell crosstalk remained unexplored. Recently, we investigated the possibility that antifibrotic effects of PCA on cardiac fibroblasts might be observed through AMPK-associated regulation of the PPAR-α/MAPK pathway and possible paracrine effects on cardiomyocytes and endothelial cells. For this purpose, human cardiac fibroblasts (HCFs) were cultured under glycemic and fibrotic conditions with or without PCA treatment, and cells were exposed to compound C to block AMPK. Afterwards, conditioned media was collected from these cells and applied to human umbilical vein endothelial cells (HUVECs) and AC16 cardiomyocytes. Our results showed that PCA significantly decreased the gene and protein expression levels of CTGF and α-SMA in HCFs, confirming its antifibrotic effects even in the presence of compound C (a potent AMPK inhibitor). Mechanistically, PCA partly modulated AMPK levels, which further upregulated levels of PPAR-α and downregulated MAPK levels. Moreover, conditioned media-treated HUVECs showed a significantly improved p-eNOS/e-NOS ratio, a molecular change associated with improved endothelial function through paracrine effects. In AC16 cardiomyocytes, there was significant reduction in troponin levels while AMPK and PPAR-α were upregulated. These findings demonstrated that PCA exerts its antifibrotic effects partly through the AMPK-associated pathway and also confers protective paracrine effects on endothelial cells and cardiomyocytes, suggesting its significant potential in DCM-associated cardiac remodeling.
No takes yet. Share an insight, caveat, or question.
Nawaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: